BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25535752)

  • 1. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV.
    Warr AJ; Anterasian C; Shah JA; De Rosa SC; Nguyen FK; Maleche-Obimbo E; Cranmer LM; Matemo D; Mecha J; Kinuthia J; LaCourse SM; John-Stewart GC; Hawn TR
    EBioMedicine; 2022 Jun; 80():104023. PubMed ID: 35533496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
    Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
    J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.
    Soares AP; Scriba TJ; Joseph S; Harbacheuski R; Murray RA; Gelderbloem SJ; Hawkridge A; Hussey GD; Maecker H; Kaplan G; Hanekom WA
    J Immunol; 2008 Mar; 180(5):3569-77. PubMed ID: 18292584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
    Mansoor N; Scriba TJ; de Kock M; Tameris M; Abel B; Keyser A; Little F; Soares A; Gelderbloem S; Mlenjeni S; Denation L; Hawkridge A; Boom WH; Kaplan G; Hussey GD; Hanekom WA
    J Infect Dis; 2009 Apr; 199(7):982-90. PubMed ID: 19236280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
    Kidzeru EB; Hesseling AC; Passmore JA; Myer L; Gamieldien H; Tchakoute CT; Gray CM; Sodora DL; Jaspan HB
    AIDS; 2014 Jun; 28(10):1421-30. PubMed ID: 24785950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4⁺IL-17⁺TNF⁺IL-2⁺ T cells.
    Cruz A; Torrado E; Carmona J; Fraga AG; Costa P; Rodrigues F; Appelberg R; Correia-Neves M; Cooper AM; Saraiva M; Pedrosa J; Castro AG
    Vaccine; 2015 Jan; 33(1):85-91. PubMed ID: 25448107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
    Mazzola TN; da Silva MT; Abramczuk BM; Moreno YM; Lima SC; Zorzeto TQ; Passeto AS; Vilela MM
    AIDS; 2011 Nov; 25(17):2079-87. PubMed ID: 21866040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteria.
    Murphy M; Suliman S; Briel L; Veldtsman H; Khomba N; Africa H; Steyn M; Snyders CI; van Rensburg IC; Walzl G; Chegou NN; Hatherill M; Hanekom WA; Scriba TJ; Nemes E
    Int J Infect Dis; 2023 May; 130 Suppl 1():S52-S62. PubMed ID: 36842756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guérin immunization.
    Mawa PA; Nkurunungi G; Egesa M; Webb EL; Smith SG; Kizindo R; Akello M; Lule SA; Muwanga M; Dockrell HM; Cose S; Elliott AM
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1671):. PubMed ID: 25964450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.
    Van Rie A; Madhi SA; Heera JR; Meddows-Taylor S; Wendelboe AM; Anthony F; Violari A; Tiemessen CT
    Clin Vaccine Immunol; 2006 Feb; 13(2):246-52. PubMed ID: 16467333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal Latent
    Lubyayi L; Mawa PA; Nabakooza G; Nakibuule M; Tushabe JV; Serubanja J; Aibo D; Akurut H; Tumusiime J; Hasso-Agopsowicz M; Kaleebu P; Levin J; Dockrell HM; Smith S; Webb EL; Elliott AM; Cose S
    Front Immunol; 2020; 11():929. PubMed ID: 32477371
    [No Abstract]   [Full Text] [Related]  

  • 19. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
    Kagina BM; Abel B; Bowmaker M; Scriba TJ; Gelderbloem S; Smit E; Erasmus M; Nene N; Walzl G; Black G; Hussey GD; Hesseling AC; Hanekom WA
    Vaccine; 2009 Sep; 27(40):5488-95. PubMed ID: 19616494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.